Literature DB >> 27829820

Simulation of positron emitters for monitoring of dose distribution in proton therapy.

Mohsen Mashayekhi1, Ali Asghar Mowlavi2, Sayyed Bijan Jia3.   

Abstract

AIM: The purpose of this work was to estimate the dependency between the produced positron emitters and the proton dose distribution as well as the dependency between points of annihilation and the proton dose distribution.
BACKGROUND: One important feature of proton therapy is that, through the non-elastic nuclear interaction of protons with the target nuclei such as 12C, 14N and 16O, it produces a small number of positron-emitting radioisotopes along the beam-path. These radioisotopes allow imaging the Bragg peak position which is related to the proton dose distribution by using positron emission tomography.
METHODS: In this study, the GEANT4 toolkit was applied to simulate a soft and bone tissue phantom in proton therapy to evaluate the positron emitter productions and the actual annihilation points of β+. Simulation was done by delivering pencil and spread-out Bragg peak (SOBP) proton beams.
RESULTS: The findings showed that (15O, 11C, 13N) and (11C, 15O, 38K, 30P, 39Ca, 13N) are the most suitable positron emitters in the soft and bone tissue respectively. By increasing the proton energy, the distance between the peak of annihilation profile and Bragg peak is almost constant, but the distance between the Bragg peak position and positron annihilation point peak in bone tissue is smaller than that in the soft tissue. The peak of β+ activity distribution becomes sharper at higher proton energies.
CONCLUSIONS: There is a good relationship between the positions of positron annihilation profile and positron emitters radioactive decay. Also, GEANT4 is a powerful and suitable tool for simulation of nuclear interactions and positron emitters in tissues.

Entities:  

Keywords:  GEANT4 toolkit; Positron emitters; Proton therapy; β+ activity distribution

Year:  2016        PMID: 27829820      PMCID: PMC5094681          DOI: 10.1016/j.rpor.2016.10.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  11 in total

1.  Potential application of PET in quality assurance of proton therapy.

Authors:  K Parodi; W Enghardt
Journal:  Phys Med Biol       Date:  2000-11       Impact factor: 3.609

2.  Study of PET intrinsic spatial resolution and contrast recovery improvement for PET/MRI systems.

Authors:  Hao Peng; Craig S Levin
Journal:  Phys Med Biol       Date:  2012-04-05       Impact factor: 3.609

3.  Measurement and verification of positron emitter nuclei generated at each treatment site by target nuclear fragment reactions in proton therapy.

Authors:  Aya Miyatake; Teiji Nishio; Takashi Ogino; Nagahiro Saijo; Hiroyasu Esumi; Mitsuru Uesaka
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

4.  In-beam PET measurements of beta+ radioactivity induced by proton beams.

Authors:  K Parodi; W Enghardt; T Haberer
Journal:  Phys Med Biol       Date:  2002-01-07       Impact factor: 3.609

5.  Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities.

Authors:  Katia Parodi; Thomas Bortfeld; Thomas Haberer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-07-01       Impact factor: 7.038

6.  Detour factors in water and plastic phantoms and their use for range and depth scaling in electron-beam dosimetry.

Authors:  J M Fernández-Varea; P Andreo; T Tabata
Journal:  Phys Med Biol       Date:  1996-07       Impact factor: 3.609

7.  Proton dose monitoring with PET: quantitative studies in Lucite.

Authors:  U Oelfke; G K Lam; M S Atkins
Journal:  Phys Med Biol       Date:  1996-01       Impact factor: 3.609

8.  Dosimetric uncertainty in prostate cancer proton radiotherapy.

Authors:  Liyong Lin; Carlos Vargas; Wen Hsi; Daniel Indelicato; Roelf Slopsema; Zuofeng Li; Daniel Yeung; Dave Horne; Jatinder Palta
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  Clinical application of in-room positron emission tomography for in vivo treatment monitoring in proton radiation therapy.

Authors:  Chul Hee Min; Xuping Zhu; Brian A Winey; Kira Grogg; Mauro Testa; Georges El Fakhri; Thomas R Bortfeld; Harald Paganetti; Helen A Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-04       Impact factor: 7.038

10.  Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy.

Authors:  Katia Parodi; Harald Paganetti; Helen A Shih; Susan Michaud; Jay S Loeffler; Thomas F DeLaney; Norbert J Liebsch; John E Munzenrider; Alan J Fischman; Antje Knopf; Thomas Bortfeld
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-07-01       Impact factor: 7.038

View more
  1 in total

1.  Simulation of dose distribution and secondary particle production in proton therapy of brain tumor.

Authors:  Zahra Hashemi; Mansoureh Tatari; Haladhara Naik
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.